Cargando…
Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
INTRODUCTION: Trimethylamine N-oxide (TMAO), a gut microbiota metabolite from dietary phosphatidylcholine, is involved in the pathogenesis of atherosclerosis and cardiovascular diseases. Psoriasis is associated with increased cardiovascular risk that is not captured by traditional biomarkers. The ai...
Autores principales: | Sikora, Mariusz, Kiss, Norbert, Stec, Albert, Giebultowicz, Joanna, Samborowska, Emilia, Jazwiec, Radoslaw, Dadlez, Michal, Olszewska, Malgorzata, Rudnicka, Lidia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322249/ https://www.ncbi.nlm.nih.gov/pubmed/33983475 http://dx.doi.org/10.1007/s13555-021-00547-3 |
Ejemplares similares
-
Clinical Implications of Intestinal Barrier Damage in Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2021) -
The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023) -
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019) -
Gut Microbiome in Psoriasis: An Updated Review
por: Sikora, Mariusz, et al.
Publicado: (2020) -
Dose-adjusted and dose/kg-adjusted concentrations of mycophenolic acid precursors reflect metabolic ratios of their metabolites in contrast with tacrolimus and cyclosporine
por: Hryniewiecka, Ewa, et al.
Publicado: (2019)